Search
Close this search box.

[:pb]A study of antituberculosis activities and crystal structures of (E)-2-[2-(arylidene)hydrazinyl]pyrimidine and (E)-N1-(arylidene)pyrimidine-2-carbohydrazide derivatives[:]

[:pb]Authors: Pinheiro, A. C.; Nogueira, Thaís C. M.; Da Costa, C. F.; Lourenço, C.; Low, J. N.; Wardell, J. L.; Wardell, Solange M. S. V.; De Souza, M. V. N.
Source: Zeitschrift Fur Naturforschung Section B-A Journal Of Chemical Sciences, v. 75, p. 1011-1028, 2020
Publisher: De Gruyter


Abstract

A study of the anti-tuberculosis activity against Mycobacterium tuberculosis ATTC 27294 and an X-ray structural determination of (E)-2-[2-(arylidene)hydrazinyl]pyrimidine, 1, and (E)-N1-(arylidene)pyrimidine-2-carbohydazide, 2, derivatives are presented. The effect of the substituents in the aryl moiety on the antituberculosis (anti-TB) activities of 1 and 2 is compared with that of other heteroaryl hydrazonyl and acylhydrazonyl derivatives. The biological activities of 1 do not depend on the coordinating ability of the substituted aryl group: in 2, the most effective aryl group is 5-nitrofuranyl. The structure determinations of (E)-2-((2-(pyrimidin-2-yl)hydrazono)methyl)-phenol, (E)-N′-(2,5-dihydroxybenzylidene)pyrimidine-2-carbohydrazide and of the hydrate of (E)-N′-(2-hydroxy-4-methylbenzylidene)pyrimidine-2-carbohydrazide, and a literature search of related structures in the CCDC data base, allowed an examination of the more important interactions, including the occurrence of X–Y⋯π interactions.

Keywords: anti-TB, (E)-2-[2-(arylidene)hydrazinyl]pyrimidines, (E)-N1-(arylidene)pyrimidine-2 carbohydazides, X-ray crystallography, π interactions

DOI: 10.1515/znb-2020-0108

Publication date:  16 de Dezembro de 2020[:]

Compartilhar publicação

Facebook
Twitter
Email
LinkedIn
WhatsApp

Deixe seu comentário

Compartilhar

Sobre a SSCDT

Nosso grupo de pesquisa está situado em Farmanguinhos e atualmente é o maior laboratório farmacêutico oficial vinculado ao Ministério da Saúde. Farmanguinhos produz mais de um bilhão de medicamentos por ano para os programas estratégicos do Governo Federal, além de atender demandas emergenciais no Brasil e no exterior.

posts Recentes